MDT

97.25

+1.88%↑

VEEV

300.62

+4.11%↑

139.72

-0.04%↓

HQY

90.34

-0.32%↓

PHR.US

23.41

+5.4%↑

MDT

97.25

+1.88%↑

VEEV

300.62

+4.11%↑

139.72

-0.04%↓

HQY

90.34

-0.32%↓

PHR.US

23.41

+5.4%↑

MDT

97.25

+1.88%↑

VEEV

300.62

+4.11%↑

139.72

-0.04%↓

HQY

90.34

-0.32%↓

PHR.US

23.41

+5.4%↑

MDT

97.25

+1.88%↑

VEEV

300.62

+4.11%↑

139.72

-0.04%↓

HQY

90.34

-0.32%↓

PHR.US

23.41

+5.4%↑

MDT

97.25

+1.88%↑

VEEV

300.62

+4.11%↑

139.72

-0.04%↓

HQY

90.34

-0.32%↓

PHR.US

23.41

+5.4%↑

Kodu・Aktsiate loetelu・NeoGenomics Inc

NeoGenomics Inc

Avatud

9.02 7.51

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

8.29

Max

9.07

Põhinäitajad
By Trading Economics
Sissetulek	-19M -45M
Müük	13M 181M
Kasumimarginaal	-24.867
Töötajad	2,200
EBITDA	-41M -48M

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+22.36% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	4. nov 2025

Turustatistika
By TradingEconomics
Turukapital	172M 1B
Eelmine avamishind	1.51
Eelmine sulgemishind	9.02

Tehniline skoor

By Trading Central

Kindlus

Very Strong Bearish Evidence

7.7 / 10.27 Toetus ja vastupanu

NeoGenomics Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

30. sept 2025, 14:35 UTC

Suurimad hinnamuutused turgudel

Robo.ai Shares Rise After $300 Million Investment From Burkhan Capital

25. sept 2025, 16:56 UTC

Suurimad hinnamuutused turgudel

PSQ Holdings Stock Slides on Plans to Launch Crypto Treasury Service

25. sept 2025, 16:31 UTC

Suurimad hinnamuutused turgudel

SharpLink Gaming Shares Fall on Plan to Tokenize Stock

25. sept 2025, 08:03 UTC

Suurimad hinnamuutused turgudel

Naver Surges on Talks With Cryptocurrency-Exchange Operator

23. sept 2025, 18:02 UTC

Suurimad hinnamuutused turgudel

Super League Shares Double After $10 Million Equity Investment From Evo Fund

23. sept 2025, 13:09 UTC

Omandamised, ülevõtmised, äriostud

Innovation Beverage Strikes Deal to Merge Into BlockFuel Energy

22. sept 2025, 17:33 UTC

Suurimad hinnamuutused turgudel

AgriFORCE Growing Systems Shares Double on New Blockchain Strategy

2. okt 2025, 13:17 UTC

Omandamised, ülevõtmised, äriostud

Bitcoin Depot: Acquisition Had No Material Impact on Reported 3Q Preliminary Results >BTM

2. okt 2025, 13:16 UTC

Omandamised, ülevõtmised, äriostud

Bitcoin Depot: Acquisition Brings U.S. Market Share to Roughly 30% >BTM

2. okt 2025, 13:16 UTC

Omandamised, ülevõtmised, äriostud

Bitcoin Depot: Acquisition Adds Over 500 Kiosks to Network >BTM

2. okt 2025, 13:15 UTC

Omandamised, ülevõtmised, äriostud

Bitcoin Depot Acquires Assets of National Bitcoin ATM, Significantly Expanding U.S. Footprint

2. okt 2025, 07:05 UTC

Market Talk

Global Equities Roundup: Market Talk

2. okt 2025, 07:05 UTC

Market Talk

Bitcoin Rises Following Wall Street Rally -- Market Talk

1. okt 2025, 23:12 UTC

Omandamised, ülevõtmised, äriostud

Avalanche Treasury CEO is Bart Smith

1. okt 2025, 23:11 UTC

Omandamised, ülevõtmised, äriostud

Avalanche Treasury Investors Include Dragonfly, VanEck, Galaxy Digital and Others

1. okt 2025, 23:07 UTC

Omandamised, ülevõtmised, äriostud

Avalanche Treasury Plans to Own More Than $1B Worth of AVAX After Becoming a Public Company

1. okt 2025, 23:06 UTC

Omandamised, ülevõtmised, äriostud

Avalanche Treasury Co. Has an Exclusive Relationship With Avalanche Foundation

1. okt 2025, 23:04 UTC

Omandamised, ülevõtmised, äriostud

Avalanche Treasury: Transaction Includes About $460M in Treasury Assets

1. okt 2025, 14:01 UTC

Market Talk

Bitcoin Rises as Weak Jobs Data Boost Rate-Cut Bets -- Market Talk

1. okt 2025, 07:27 UTC

Market Talk

Bitcoin Edges Lower as U.S. Government Shut Down Begins -- Market Talk

30. sept 2025, 14:20 UTC

Suurimad hinnamuutused turgudel

Robo.ai Shares Rise After $300M Investment From Burkhan Capital

30. sept 2025, 06:51 UTC

Market Talk

Bitcoin Eases as Possible U.S. Government Shutdown Looms -- Market Talk

29. sept 2025, 13:48 UTC

Market Talk

Seasonality Could Favor Bitcoin in Coming Months -- Market Talk

29. sept 2025, 07:40 UTC

Market Talk

Bitcoin Recovers But Remains at Risk of Renewed Losses -- Market Talk

26. sept 2025, 07:29 UTC

Market Talk

Bitcoin Stabilizes After Steep Falls; Focus Turns to U.S. PCE Data -- Market Talk

25. sept 2025, 09:16 UTC

Market Talk

Bitcoin Falls as Investors Await U.S. Data -- Market Talk

24. sept 2025, 12:50 UTC

Omandamised, ülevõtmised, äriostud

Fitell Corp Completes Initial $10M Solana Purchase Following the First Closing Under $100M Financing Facility

24. sept 2025, 06:55 UTC

Market Talk

Bitcoin Stays Weak After Powell Remarks -- Market Talk

23. sept 2025, 17:47 UTC

Suurimad hinnamuutused turgudel

Super League Shares Double After $10M Equity Investment From Evo Fund

22. sept 2025, 20:36 UTC

Omandamised, ülevõtmised, äriostud

Scaramucci-Backed Crypto Treasury Company Launches With $550 Million Fundraising Plan -- Update

Võrdlus sarnastega

Hinnamuutus

NeoGenomics Inc Prognoos

Hinnasiht

By TipRanks

22.36% tõus

12 kuu keskmine prognoos

Keskmine 10.67 USD 22.36%

Kõrge 14 USD

Madal 8 USD

Põhineb 11 Wall Streeti analüütiku instrumendi NeoGenomics Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

11 ratings

Osta

Hoia

Müü

Põhineb 11 analüütiku instrumendi NeoGenomics Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

7.7 / 10.27Toetus ja vastupanu

Recent bearish events outweigh bullish events.

All events are bearish.

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.